Measuring What Matters: PROMs in Urticaria Care

Measuring What Matters: PROMs in Urticaria Care

In this episode of the GA²LEN (Global Allergy and Asthma Excellence Network) Podcast on Everything Urticaria, Professor Torsten Zuberbier talks with Dr. Karsten Weller, a leading expert and developer of patient-reported outcome measures (PROMs), about how these tools are transforming the management of urticaria and angioedema in both research and daily care.


The discuss:

🔹 What are PROMs and why are they essential in urticaria management?
🔹 How are they developed and validated scientifically?
🔹 Which tools should clinicians use in everyday practice?
🔹 What does the future hold for digital and app-based patient assessment?

Dr. Weller explains how PROMs such as the Urticaria Control Test (UCT) help physicians understand disease control directly from the patient’s perspective. He discusses the scientific process of developing and validating PROMs, the benefits of integrating them into digital tools like the CRUSE App, and how simple, standardized communication enhances care. Together, they explore the future of patient-centered assessment, from wearable technologies to the evolving language of quality-of-life measures.


Key Learnings from the Episode:

PROMs capture the patient’s own perception of disease activity, control, and quality of life—crucial for fluctuating conditions like urticaria.

The Urticaria Control Test (UCT) is a quick, validated 4-question tool recommended for every patient visit.

PROM development follows a rigorous process including patient input, expert review, and validation studies.

Tools like the Chronic Urticaria QoL Questionnaire (CU-Q2oL) and Angioedema QoL Questionnaire (AE-QoL) add depth when time allows.

Digital apps such as the CRUSE App integrate PROMs into daily life and facilitate doctor–patient communication.

Despite new technologies, the patient’s direct voice remains irreplaceable in capturing holistic well-being.

The language of questionnaires must be periodically reviewed to stay clear and relevant across generations.

PROMs promote standardized, efficient, and patient-centered care, empowering better decisions and stronger engagement.


Chapters

00:00 Introduction to Patient-Reported Outcome Measures (PROMs)

03:23 The Development Process of PROMs

05:57 Practical Application of PROMs in Clinical Practice

08:40 The Future of Digital Tools in Patient Care

11:28 Language and Communication in Patient-Reported Outcomes

14:10 Final Thoughts and Conclusion


Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.

Feedback form: ATU: ⁠⁠⁠⁠⁠https://forms.office.com/e/m6a2uEdsUH

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(121)

AI and the Future of Urticaria

AI and the Future of Urticaria

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intellig...

16 Kesä 16min

Urticaria Triggers: Infection Insights

Urticaria Triggers: Infection Insights

In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chroni...

19 Touko 16min

A New Era in Urticaria Treatment

A New Era in Urticaria Treatment

In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released inte...

23 Huhti 19min

Managing Urticaria in Resource-Limited Settings

Managing Urticaria in Resource-Limited Settings

In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Dr. Emma Kruger from Cape Town, South Africa, about managing urticar...

24 Maalis 17min

Drug Survival of Omalizumab

Drug Survival of Omalizumab

In this episode of the Urticaria podcast series, Prof. Torsten Zuberbier speaks with Reineke Soegiharto, PhD candidate and dermatology resident from UMC Utrecht, about the international UCARE study DR...

24 Helmi 17min

Visualizing Urticaria Worldwide

Visualizing Urticaria Worldwide

In this episode of the GA²LEN Urticaria Podcast, Professor Torsten Zuberbier is joined by Professor Simon Francis Thomsen from Denmark to introduce an exciting new global initiative within the UCARE n...

28 Tammi 19min

A New Era for Urticaria Treatment

A New Era for Urticaria Treatment

In this short, conference-based episode, Professor Torsten Zuberbier, President of Global Allergy and Asthma Excellence Network, speaks with Professor Kiran Godse from Mumbai, India, directly from the...

18 Joulu 20255min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-hereilla
hippokrateen-vastaanotolla
tiedekulma-podcast
utelias-mieli
rss-duodecim-lehti
rss-astetta-parempi-elama-podcast
rss-jyvaskylan-yliopisto
rss-lihavuudesta-podcast
university-of-eastern-finland
ihanat-ipanat
docemilia
sotataidon-ytimessa
rss-ranskaa-raakana
rss-laakaripodi
rss-alycast-alykasta-laakehoitoa-yksilollisesti